id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-263521-kv3l41qz	Haigh, Kathryn	Hyperinflammation with Covid-19: the key to patient deterioration?()()	2020-05-24		.txt	text/plain	882	70	56	BACKGROUND: The potential risk of cytokine storm in patients with coronavirus disease 2019 (Covid-19) has been described(1); we write to share our experience treating a 17-year-old male with haemophagocytic lymphohistiocytosis (HLH) secondary to Covid-19 infection. Considering Russell and colleagues'(3) comments about potential harm of corticosteroid use in patients with Covid-19 infection, the patient was commenced on treatment with the selective IL-1 receptor antagonist drug, Anakinra, and a two day course of intravenous immunoglobulin. The potential risk of cytokine storm in patients with coronavirus disease 2019 (Covid-19) has been described 1 ; we write to share our experience treating a 17-year-old male with haemophagocytic lymphohistiocytosis (HLH) secondary to Covid-19. After five days of piperacillintazobactam, intravenous meropenem 1 gram three times a day was started as his liver function tests had not yet stabilised and there was concern that the piperacillin-tazobactam The patient responded rapidly to treatment, becoming apyrexial after 24 hours of Anakinra.	./cache/cord-263521-kv3l41qz.txt	./txt/cord-263521-kv3l41qz.txt